. Targeting Lewy body dementia with neflamapimod-rasagiline hybrids. Arch Pharm (Weinheim). 2024 Jun;357(6):e2300525. Epub 2024 Feb 27 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.